305 related articles for article (PubMed ID: 30506570)
1. Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.
Fang JH; Xu L; Shang LR; Pan CZ; Ding J; Tang YQ; Liu H; Liu CX; Zheng JL; Zhang YJ; Zhou ZG; Xu J; Zheng L; Chen MS; Zhuang SM
Hepatology; 2019 Sep; 70(3):824-839. PubMed ID: 30506570
[TBL] [Abstract][Full Text] [Related]
2. Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment.
Negri FV; Dal Bello B; Porta C; Campanini N; Rossi S; Tinelli C; Poggi G; Missale G; Fanello S; Salvagni S; Ardizzoni A; Maria SE
Liver Int; 2015 Aug; 35(8):2001-8. PubMed ID: 25559745
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacy.
Estfan B; Byrne M; Kim R
Am J Clin Oncol; 2013 Aug; 36(4):319-24. PubMed ID: 22547010
[TBL] [Abstract][Full Text] [Related]
4. Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular Carcinoma.
Renne SL; Woo HY; Allegra S; Rudini N; Yano H; Donadon M; Viganò L; Akiba J; Lee HS; Rhee H; Park YN; Roncalli M; Di Tommaso L
Hepatology; 2020 Jan; 71(1):183-195. PubMed ID: 31206715
[TBL] [Abstract][Full Text] [Related]
5. Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma.
Wang JH; Li XS; Tang HS; Fang RY; Song JJ; Feng YL; Guan TP; Ruan Q; Wang J; Cui SZ
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4163-4172. PubMed ID: 36050540
[TBL] [Abstract][Full Text] [Related]
6. Duration of stable disease is associated with overall survival in patients with advanced hepatocellular carcinoma treated with sorafenib.
Arizumi T; Ueshima K; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Sakurai T; Nishida N; Kudo M
Dig Dis; 2014; 32(6):705-10. PubMed ID: 25376287
[TBL] [Abstract][Full Text] [Related]
7. Decreased blood flow after sorafenib administration is an imaging biomarker to predict overall survival in patients with advanced hepatocellular carcinoma.
Arizumi T; Ueshima K; Chishina H; Kono M; Takita M; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Sakurai T; Nishida N; Kudo M
Dig Dis; 2014; 32(6):733-9. PubMed ID: 25376291
[TBL] [Abstract][Full Text] [Related]
8. A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion.
Lu L; Wei W; Huang C; Li S; Zhong C; Wang J; Yu W; Zhang Y; Chen M; Ling Y; Guo R
Hepatol Int; 2021 Jun; 15(3):651-662. PubMed ID: 33835379
[TBL] [Abstract][Full Text] [Related]
9. Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma.
Godin C; Bodeau S; Saidak Z; Louandre C; François C; Barbare JC; Coriat R; Galmiche A; Sauzay C
Oncol Rep; 2019 Mar; 41(3):2041-2050. PubMed ID: 30569112
[TBL] [Abstract][Full Text] [Related]
10. Randomized Phase II Study of the X-linked Inhibitor of Apoptosis (XIAP) Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC).
Lee FA; Zee BC; Cheung FY; Kwong P; Chiang CL; Leung KC; Siu SW; Lee C; Lai M; Kwok C; Chong M; Jolivet J; Tung S
Am J Clin Oncol; 2016 Dec; 39(6):609-613. PubMed ID: 24977690
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib.
Chen D; Zhao P; Li SQ; Xiao WK; Yin XY; Peng BG; Liang LJ
Eur J Surg Oncol; 2013 Sep; 39(9):974-80. PubMed ID: 23845703
[TBL] [Abstract][Full Text] [Related]
12. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial.
Pinyol R; Montal R; Bassaganyas L; Sia D; Takayama T; Chau GY; Mazzaferro V; Roayaie S; Lee HC; Kokudo N; Zhang Z; Torrecilla S; Moeini A; Rodriguez-Carunchio L; Gane E; Verslype C; Croitoru AE; Cillo U; de la Mata M; Lupo L; Strasser S; Park JW; Camps J; Solé M; Thung SN; Villanueva A; Pena C; Meinhardt G; Bruix J; Llovet JM
Gut; 2019 Jun; 68(6):1065-1075. PubMed ID: 30108162
[TBL] [Abstract][Full Text] [Related]
13. Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma.
Peng S; Wang Y; Peng H; Chen D; Shen S; Peng B; Chen M; Lencioni R; Kuang M
Hepatology; 2014 Oct; 60(4):1264-77. PubMed ID: 24849467
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.
Chen ZY; Guo ZX; Lu LH; Mei J; Lin WP; Li SH; Wei W; Guo RP
Cancer Med; 2021 Aug; 10(16):5466-5474. PubMed ID: 34212527
[TBL] [Abstract][Full Text] [Related]
15. Effect of vessels that encapsulate tumor clusters (VETC) on the prognosis of different stages of hepatocellular carcinoma after hepatectomy.
Wang YY; Dong K; Wang K; Sun Y; Xing BC
Dig Liver Dis; 2023 Sep; 55(9):1288-1294. PubMed ID: 37037766
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.
Chen L; Su H; Shao H; Xu K; Liang S; Liu J
Hepatogastroenterology; 2014 May; 61(131):802-8. PubMed ID: 26176077
[TBL] [Abstract][Full Text] [Related]
17. The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib.
Sarpel U; Spivack JH; Berger Y; Heskel M; Aycart SN; Sweeney R; Edwards MP; Labow DM; Kim E
HPB (Oxford); 2016 May; 18(5):411-8. PubMed ID: 27154804
[TBL] [Abstract][Full Text] [Related]
18. Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.
Parikh ND; Marshall VD; Singal AG; Nathan H; Lok AS; Balkrishnan R; Shahinian V
Hepatology; 2017 Jan; 65(1):122-133. PubMed ID: 27770556
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of a Novel Nomogram for Predicting Vessels that Encapsulate Tumor Cluster in Hepatocellular Carcinoma.
Guan R; Lin W; Zou J; Mei J; Wen Y; Lu L; Guo R
Cancer Control; 2022; 29():10732748221102820. PubMed ID: 35609265
[TBL] [Abstract][Full Text] [Related]
20. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner.
Fang JH; Zhou HC; Zhang C; Shang LR; Zhang L; Xu J; Zheng L; Yuan Y; Guo RP; Jia WH; Yun JP; Chen MS; Zhang Y; Zhuang SM
Hepatology; 2015 Aug; 62(2):452-65. PubMed ID: 25711742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
